DOPAMINE HYDROCHLORIDE

Post-LOE

dopamine hydrochloride

Hikma

ANDAINJECTIONINJECTABLE

Approved

Apr 2018

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

Drug Shortage Active

DOPAMINE HYDROCHLORIDE is currently in shortage. Reason: Unavailable. This may impact manufacturing, supply chain, and quality hiring at the manufacturer.

DOPAMINE HYDROCHLORIDE (dopamine hydrochloride) by Hikma is 12. Approved for hemodynamic status in patients in shock. First approved in 2018.

Drug data last refreshed 18h ago

Mechanism of Action

12.1 Mechanism of Action Dopamine is a natural catecholamine formed by the decarboxylation of 3,4 dihydroxyphenylalanine (DOPA). It is a precursor to norepinephrine in noradrenergic nerves and is also a neurotransmitter in certain areas of the central nervous system, especially in the nigrostriatal…

Worked on DOPAMINE HYDROCHLORIDE at Hikma? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

DOPAMINE HYDROCHLORIDE

Mechanism of Action

Indications (1)